Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
The impact of sex on allergic bronchopulmonary aspergillosis (ABPA) outcomes remains uncertain. We retrospectively included ABPA subjects per the revised International Society for Human and Animal Mycology ABPA working group criteria over 13 years. We compared the clinical features, lung function, immunological tests, imaging, and ABPA exacerbation rates between men and women. Our primary objective was to assess whether women experience higher ABPA exacerbations than men. We included 731 ABPA subjects (mean age, 34.5 years; 49.5% women). Women with ABPA were older and had underlying asthma more frequently than men. There was no difference in lung function, immunological investigations, and imaging between men and women. ABPA exacerbations occurred in a slightly higher proportion of women than men (44.5% vs. 38.2%) but did not reach statistical significance (p = 0.09). We did not find a significant sex difference in ABPA exacerbation rates. Prospective studies should confirm our findings.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s11046-024-00893-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Duo biologic therapy using mepolizumab and omalizumab in refractory ABPA: two cases.
Allergy Asthma Clin Immunol
September 2025
Department of Physiological Science, University of California, 986 N Center Street, Orange, Los Angeles, CA, 90095, USA.
Background: Allergic bronchopulmonary aspergillosis (ABPA) presents with a wide range of symptom severity, with severe disease manifestations being harder to control through conventional inhalers. While corticosteroids remain a standard treatment option, their use is often hindered by significant adverse side effects. This case series discusses a novel treatment of duo-administration of monoclonal antibodies for two patients that reduced their exacerbations, spared the use of steroids, and improved their quality of life.
View Article and Find Full Text PDFHealthy Homes, Healthy Lungs: The Role of Home Insulation in Environmental Impact on People With Cystic Fibrosis.
Pediatr Pulmonol
August 2025
Division of Paediatric Pulmonology, Marmara University School of Medicine, Istanbul, Turkey.
Background: People with CF (pwCF) constantly strive for lung health, making environmental factors a crucial aspect of comprehensive care. This study investigated the impact of home insulation on the respiratory health of individuals with CF, focusing on dampness and mold as potential environmental factors. We hypothesize that improved living conditions, specifically adequate home insulation, have a positive impact on lung health in pwCF by reducing exposure to environmental risk factors such as dampness and mold.
View Article and Find Full Text PDFAllergic Bronchopulmonary Aspergillosis Misdiagnosed as Non-resolving Pneumonia: A Case Report.
Saudi J Med Med Sci
July 2025
Department of Internal Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Allergic bronchopulmonary aspergillosis (ABPA) is a hypersensitivity reaction triggered by colonization of the airways that primarily affects immunocompetent individuals, particularly those with asthma. ABPA can often be misdiagnosed as severe asthma or non-resolving pneumonia, leading to delays in appropriate management. Early recognition of ABPA is crucial to prevent disease progression and unnecessary antibiotic use.
View Article and Find Full Text PDFMonitoring treatment response using serial PTX3 levels in chronic and invasive pulmonary aspergillosis.
Clin Chim Acta
August 2025
School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Division of Clinical Skills Training, Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Division of
Background: Pentraxin 3 (PTX3) is an innate immune biomarker involved in host defense against Aspergillus species. While elevated PTX3 levels have been observed in various infection states, its utility in monitoring treatment response in pulmonary aspergillosis remains underexplored.
Methods: We assessed serial PTX3 levels in total 216 patients with chronic pulmonary aspergillosis (CPA, n = 48) and invasive pulmonary aspergillosis (IPA, n = 48) before and after antifungal therapy.
Association between allergic bronchopulmonary aspergillosis or Aspergillus sensitization and tuberculosis: A systematic review of 607 cases.
J Infect Chemother
August 2025
Department of Medicine, AIIMS, New Delhi, India. Electronic address:
Introduction: Although allergic bronchopulmonary aspergillosis (ABPA) is classically described in asthma and cystic fibrosis, pulmonary tuberculosis (PTB) with post-tubercular lung disease (PTLD) has been reported as a likely predisposing factor. It, however, has not been reviewed systematically, which we aimed to achieve in the current systematic review.
Methods: We screened the available literature from PubMed, Embase, SCOPUS and Web of Science databases for studies reporting association between ABPA and PTB from the beginning of time to June 30, 2023 and collated the data on association of ABPA and tuberculosis.